Millipore acquires Guava

LCGC Europe eNews

LCGC Europe eNews-02-20-2009, Volume 0, Issue 0

Millipore has announced that it will be acquiring Guava Technologies. The agreement, which is expected to close in the next two weeks, will see Millipore pay around $22.6 million. This follows the distribution and co-development partnership that the two companies announced in March 2008.

Millipore has announced that it will be acquiring Guava Technologies. The agreement, which is expected to close in the next two weeks, will see Millipore pay around $22.6 million. This follows the distribution and co-development partnership that the two companies announced in March 2008.

This deal is expected to allow the two companies to integrate their instrumentation, reagent kits, validated protocols and technical support which, the companies claim, will bring the advantages of flow cytometry to the bench tops of cell biologists.

“Our vision is to make flow cytometry less expensive, easier to use, and more accessible for all research scientists,” said Jonathan DiVincenzo, president of Millipore’s bioscience division. “Additionally, by developing kits that are optimized for key research areas such as stem cell research, cancer biology, cell health, and biomarker discovery, scientists will no longer need to source reagents and develop their own assays.”

Information about Guava Technologies is available on the website: www.guavatechnologies.com

More about Millipore can be found at: www.millipore.com